Znanstveni rad - Izvorni znanstveni rad
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
New England Journal of Medicine, 375 (2016), 20; 1946-1960. https://doi.org/10.1056/NEJMoa1602773

(UNITI–IM-UNITI Study Group) Feagan, Brian G.; Sandborn, William J.; Gasink, Christopher; Jacobstein, Douglas; Lang, Yinghua; Friedman, Joshua R.; Blank, Marion A.; Johanns, Jewel; Gao, Long-Long; Miao, Ye; Adedokun, Omoniyi J.; Sands, Bruce E.; Hanauer, Stephen B.; Vermeire, Severine; Targan, Stephan; Ghosh, Subrata; de Villiers, Willem J.; Colombel, Jean-Frédéric; Tulassay, Zsolt; Seidler, Ursula; Salzberg, Bruce A.; Desreumaux, Pierre; Lee, Scott D.; Loftus, Edward V.; Dieleman, Levinus A.; Katz, Seymour; Rutgeerts, Paul; Štimac, Davor Više autora...

Citirajte ovaj rad

Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R. ... Štimac, D. (2016). Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease. New England Journal of Medicine, 375. (20), 1946-1960. doi: 10.1056/NEJMoa1602773

Feagan, Brian G., et al. "Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease." New England Journal of Medicine, vol. 375, br. 20, 2016, str. 1946-1960. https://doi.org/10.1056/NEJMoa1602773

Feagan, Brian G., William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion A. Blank, et al. "Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease." New England Journal of Medicine 375, br. 20 (2016): 1946-1960. https://doi.org/10.1056/NEJMoa1602773

Feagan, B. G., et al. (2016) 'Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease', New England Journal of Medicine, 375(20), str. 1946-1960. doi: 10.1056/NEJMoa1602773

Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, i sur.. Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease. New England Journal of Medicine [Internet]. 17.11.2016. [pristupljeno 27.05.2024.];375(20):1946-1960. doi: 10.1056/NEJMoa1602773

B. G. Feagan, et al., "Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease", New England Journal of Medicine, vol. 375, br. 20, str. 1946-1960, Studeni 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:031621. [Citirano: 27.05.2024.]